Title
Immunotherapy for the Treatment of Hematologic Malignancies: Multiple Myeloma, Lymphoma, and Acute Leukemia
Authoring Organization
Publication Month/Year
December 20, 2016
Last Updated Month/Year
January 16, 2024
Supplemental Implementation Tools
Document Type
Consensus
External Publication Status
Update_in_progress
Country of Publication
US
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment, Management
Diseases/Conditions (MeSH)
D008223 - Lymphoma, D007938 - Leukemia, D009101 - Multiple Myeloma
Keywords
multiple myeloma, hematologic malignancies, lymphoma, acute leukemia
Source Citation
Boyiadzis M, Bishop MR, Abonour R, et al; The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia; Journal for ImmunoTherapy of Cancer 2016;4:90. doi: 10.1186/s40425-016-0188-z